Home Other Building Blocks 196597-26-9
196597-26-9,MFCD08067736
Catalog No.:AA0038TN

196597-26-9 | (S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$13.00   $9.00
- +
2mg
98%
in stock  
$19.00   $14.00
- +
5mg
98%
in stock  
$34.00   $24.00
- +
10mg
98%
in stock  
$46.00   $32.00
- +
25mg
95%
in stock  
$72.00   $50.00
- +
50mg
98%
in stock  
$74.00   $52.00
- +
250mg
98%
in stock  
$139.00   $97.00
- +
1g
98%
in stock  
$346.00   $242.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0038TN
Chemical Name:
(S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide
CAS Number:
196597-26-9
Molecular Formula:
C16H21NO2
Molecular Weight:
259.3434
MDL Number:
MFCD08067736
SMILES:
CCC(=O)NCC[C@@H]1CCc2c1c1CCOc1cc2
Properties
Computed Properties
 
Complexity:
331  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
4  
XLogP3:
2.7  

Downstream Synthesis Route

[1]Uchikawa,Osamu;Fukatsu,Kohji;Tokunoh,Ryosuke;Kawada,Mitsuru;Matsumoto,Kiyoharu;Imai,Yumi;Hinuma,Shuji;Kato,Koki;Nishikawa,Hisao;Hirai,Keisuke;Miyamoto,Masaomi;Ohkawa,Shigenori[JournalofMedicinalChemistry,2002,vol.45,#19,p.4222-4239]

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US6034239,2000,A

(S)-2-(1,6,7,8-tetrahydro-2H-indeno5,4-bfuran-8-yl)-ethylaminehydrochloride 
  79-03-8    196597-26-9 

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP1792899,2007,A1Locationinpatent:Page/Pagecolumn16

[2]CurrentPatentAssignee:USVLTD.-WO2010/41271,2010,A2Locationinpatent:Page/Pagecolumn33

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US6348485,2002,B1

[4]CurrentPatentAssignee:SUNPHARMACEUTICALINDUSTRIESLIMITED-WO2011/27323,2011,A1Locationinpatent:Page/Pagecolumn12-13

[5]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP1199304,2002,A1Locationinpatent:Example19

[6]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2010/45565,2010,A1Locationinpatent:Page/Pagecolumn35-36

[7]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2010/45565,2010,A1Locationinpatent:Page/Pagecolumn42

[8]Yamano,Toru;Yamashita,Masayuki;Adachi,Mari;Tanaka,Mitsutaka;Matsumoto,Kiyoharu;Kawada,Mitsuru;Uchikawa,Osamu;Fukatsu,Kohji;Ohkawa,Shigenori[TetrahedronAsymmetry,2006,vol.17,#2,p.184-190]

[9]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US6034239,2000,A

[10]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-US2009/281176,2009,A1Locationinpatent:Page/Pagecolumn17

[11]CurrentPatentAssignee:INDUSTRIALECHIMICAS.R.L.;INDCHIMICA;INDCHIMICAITALIANLIABILITY-WO2010/103553,2010,A1Locationinpatent:Page/Pagecolumn38

[12]CurrentPatentAssignee:KANSALVINODKUMARDR;LIFSHITZREVITAL;TEVAPHARMACEUTICALINDUSTRIESLTD.;MISTRYDHIRENKUMAR-WO2008/151170,2008,A2Locationinpatent:Page/Pagecolumn52

[13]CurrentPatentAssignee:KANSALVINODKUMARDR;LIFSHITZREVITAL;TEVAPHARMACEUTICALINDUSTRIESLTD.;MISTRYDHIRENKUMAR-WO2008/151170,2008,A2Locationinpatent:Page/Pagecolumn52

[14]CurrentPatentAssignee:KANSALVINODKUMARDR;LIFSHITZREVITAL;TEVAPHARMACEUTICALINDUSTRIESLTD.;MISTRYDHIRENKUMAR-WO2008/151170,2008,A2Locationinpatent:Page/Pagecolumn52-53

[1]Yamano,Toru;Yamashita,Masayuki;Adachi,Mari;Tanaka,Mitsutaka;Matsumoto,Kiyoharu;Kawada,Mitsuru;Uchikawa,Osamu;Fukatsu,Kohji;Ohkawa,Shigenori[TetrahedronAsymmetry,2006,vol.17,#2,p.184-190]

[1]Yamano,Toru;Yamashita,Masayuki;Adachi,Mari;Tanaka,Mitsutaka;Matsumoto,Kiyoharu;Kawada,Mitsuru;Uchikawa,Osamu;Fukatsu,Kohji;Ohkawa,Shigenori[TetrahedronAsymmetry,2006,vol.17,#2,p.184-190]

[2]Zhang,Xuan;Yuan,Wei;Luo,Yu;Huang,Qing-Qing;Lu,Wei[Heterocycles,2012,vol.85,#1,p.73-84]

[3]CurrentPatentAssignee:KANSALVINODKUMARDR;LIFSHITZREVITAL;TEVAPHARMACEUTICALINDUSTRIESLTD.;MISTRYDHIRENKUMAR-WO2008/151170,2008,A2

[1]TetrahedronAsymmetry,2006,vol.17,p.184-190

[2]Patent:CN106588840,2017,A

[3]Patent:WO2008/150953,2008,A1

[4]Patent:WO2008/151170,2008,A2

[5]Patent:WO2008/151170,2008,A2

Literature

Title: Cardiovascular effects of melatonin receptor agonists.

Journal: Expert opinion on investigational drugs 20121101

Title: Ramelteon dose escalation in a patient with substance misuse.

Journal: Journal of clinical psychopharmacology 20121001

Title: Ramelteon ingestions reported to Texas poison centers, 2005-2009.

Journal: The Journal of emergency medicine 20120901

Title: Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system.

Journal: Central nervous system agents in medicinal chemistry 20120901

Title: Emerging treatment for chronic migraine and refractory chronic migraine.

Journal: Expert opinion on emerging drugs 20120901

Title: Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis.

Journal: International journal of clinical practice 20120901

Title: Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.

Journal: Molecular carcinogenesis 20120801

Title: Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.

Journal: Chronobiology international 20120801

Title: Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial.

Journal: Clinical pharmacology and therapeutics 20120601

Title: Pharmacotherapy of insomnia.

Journal: Expert opinion on pharmacotherapy 20120601

Title: [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20120601

Title: Melatonin and its analogs in insomnia and depression.

Journal: Journal of pineal research 20120501

Title: [Delirium, insomnia in hospitalization and ramelteon].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20120501

Title: [Report of the 5th meeting of Japanese Child Sleep Association].

Journal: No to hattatsu = Brain and development 20120501

Title: Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.

Journal: CNS & neurological disorders drug targets 20120301

Title: Chronic ramelteon treatment in a mouse model of Alzheimer's disease.

Journal: Archives italiennes de biologie 20120301

Title: Augmentation with ramelteon to achieve remission in geriatric major depression.

Journal: Psychiatry and clinical neurosciences 20120201

Title: The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.

Journal: Parkinson's disease 20120101

Title: Health care costs in US patients with and without a diagnosis of osteoarthritis.

Journal: Journal of pain research 20120101

Title: Emerging targets for the pharmacological treatment of depression: focus on melatonergic system.

Journal: Current medicinal chemistry 20120101

Title: The relationship of primary health care use with persistence of insomnia: a prospective cohort study.

Journal: BMC family practice 20120101

Title: Hypnotics' association with mortality or cancer: a matched cohort study.

Journal: BMJ open 20120101

Title: Circadian and wakefulness-sleep modulation of cognition in humans.

Journal: Frontiers in molecular neuroscience 20120101

Title: cGMP-phosphodiesterase inhibition enhances photic responses and synchronization of the biological circadian clock in rodents.

Journal: PloS one 20120101

Title: Gender differences in highway driving performance after administration of sleep medication: a review of the literature.

Journal: Traffic injury prevention 20120101

Title: Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction.

Journal: TheScientificWorldJournal 20120101

Title: Recent progress in the development of agonists and antagonists for melatonin receptors.

Journal: Current medicinal chemistry 20120101

Title: Toward the definition of stereochemical requirements for MT2-selective antagonists and partial agonists by studying 4-phenyl-2-propionamidotetralin derivatives.

Journal: Journal of medicinal chemistry 20111222

Title: Melatonin receptor agonists: new options for insomnia and depression treatment.

Journal: CNS neuroscience & therapeutics 20111201

Title: Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia.

Journal: Journal of clinical psychopharmacology 20111001

Title: Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.

Journal: Sleep medicine 20111001

Title: Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia.

Journal: Expert review of neurotherapeutics 20111001

Title: The challenges of interpreting residual effects of hypnotics.

Journal: Sleep 20111001

Title: Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.

Journal: Sleep 20111001

Title: Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Journal: Therapeutic advances in neurological disorders 20110901

Title: An historical view of the pineal gland and mental disorders.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20110801

Title: Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands.

Journal: Journal of medicinal chemistry 20110623

Title: Ramelteon and improved insomnia in alcohol-dependent patients: a case series.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20110615

Title: Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20110601

Title: Night-to-night variability of sleep latency significantly predicts the magnitude of subsequent change in sleep latency during placebo administration.

Journal: Sleep medicine 20110601

Title: Neurochemical and neuropharmacological aspects of circadian disruptions: an introduction to asynchronization.

Journal: Current neuropharmacology 20110601

Title: 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists.

Journal: Journal of medicinal chemistry 20110512

Title: Insomnia: a therapeutic review for pharmacists.

Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110501

Title: Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands.

Journal: Bioorganic & medicinal chemistry letters 20110215

Title: Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder.

Journal: Journal of affective disorders 20110201

Title: Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN mice.

Journal: Chronobiology international 20110201

Title: Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia.

Journal: Sleep medicine 20110201

Title: Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia.

Journal: Sleep medicine 20110201

Title: Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.

Journal: Expert review of neurotherapeutics 20110201

Title: A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance.

Journal: International clinical psychopharmacology 20110101

Title: Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.

Journal: International journal of Alzheimer's disease 20110101

Title: Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature.

Journal: Research in developmental disabilities 20110101

Title: Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications.

Journal: Neuroendocrinology 20110101

Title: Pharmacological advances in the treatment of insomnia.

Journal: Current pharmaceutical design 20110101

Title: Are melatonin and its receptor agonist specific antihypertensive modulators of resistant hypertension caused by disrupted circadian rhythm?

Journal: Journal of the American Society of Hypertension : JASH 20110101

Title: Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP).

Journal: International journal of general medicine 20110101

Title: Melatonin in mitochondrial dysfunction and related disorders.

Journal: International journal of Alzheimer's disease 20110101

Title: Clinical uses of melatonin in pediatrics.

Journal: International journal of pediatrics 20110101

Title: Treatment of delirium with ramelteon: initial experience in three patients.

Journal: General hospital psychiatry 20110101

Title: Efficient synthesis of [¹¹C]ramelteon as a positron emission tomography probe for imaging melatonin receptors involved in circadian rhythms.

Journal: Chemical & pharmaceutical bulletin 20110101

Title: Prevalence and factors associated with off-label antidepressant prescriptions for insomnia.

Journal: Drug, healthcare and patient safety 20110101

Title: Melatonin in Chagas' disease. Possible therapeutic value.

Journal: Medicina 20110101

Title: Disrupted chronobiology of sleep and cytoprotection in obesity: possible therapeutic value of melatonin.

Journal: Neuro endocrinology letters 20110101

Title: Ramelteon prior to a short evening nap impairs neurobehavioral performance for up to 12 hours after awakening.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20101215

Title: Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20101215

Title: Melatonin alters age-related changes in transcription factors and kinase activation.

Journal: Neurochemical research 20101201

Title: Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs.

Journal: Advances in therapy 20101101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view.

Journal: Current drug metabolism 20101101

Title: Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.

Journal: Neurocase 20101001

Title: Melatonin: pharmacological aspects and clinical trends.

Journal: The International journal of neuroscience 20100901

Title: [The newer sedative-hypnotics].

Journal: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20100901

Title: Neurotoxins: free radical mechanisms and melatonin protection.

Journal: Current neuropharmacology 20100901

Title: A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.

Journal: Current neuropharmacology 20100901

Title: Metabolism of ramelteon in human liver microsomes and correlation with the effect of fluvoxamine on ramelteon pharmacokinetics.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20100801

Title: [Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).].

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20100701

Title: Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel.

Journal: Sleep medicine 20100601

Title: Effects of the melatonin MT-1/MT-2 agonist ramelteon on daytime body temperature and sleep.

Journal: Sleep 20100601

Title: Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats.

Journal: Annals of the New York Academy of Sciences 20100601

Title: A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.

Journal: International clinical psychopharmacology 20100501

Title: Potential use of melatonergic drugs in analgesia: mechanisms of action.

Journal: Brain research bulletin 20100316

Title: MT1 melatonin receptors mediate somatic, behavioral, and reproductive neuroendocrine responses to photoperiod and melatonin in Siberian hamsters (Phodopus sungorus).

Journal: Endocrinology 20100201

Title: Melatonin agonists and insomnia.

Journal: Expert review of neurotherapeutics 20100201

Title: Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications.

Journal: The Journal of neuropsychiatry and clinical neurosciences 20100101

Title: Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.

Journal: BMC medicine 20100101

Title: Diagnosis and treatment of chronic insomnia.

Journal: Annals of Indian Academy of Neurology 20100101

Title: Insomnia medication use and the probability of an accidental event in an older adult population.

Journal: Drug, healthcare and patient safety 20100101

Title: Indian research on sleep disorders.

Journal: Indian journal of psychiatry 20100101

Title: Effects of ramelteon and triazolam in a mouse genetic model of early morning awakenings.

Journal: Brain research 20091103

Title: Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology 20091101

Title: Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.

Journal: The Journal of pharmacology and experimental therapeutics 20090901

Title: Anticonvulsant effects of the selective melatonin receptor agonist ramelteon.

Journal: Epilepsy & behavior : E&B 20090901

Title: Treatment of sleep dysfunction and psychiatric disorders.

Journal: Current treatment options in neurology 20090901

Title: Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology 20090901

Title: Therapies for insomnia and comorbid chronic obstructive pulmonary disease with a focus on ramelteon (rozerem).

Journal: P & T : a peer-reviewed journal for formulary management 20090901

Title: Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090815

Title: [A novel therapeutic drug: ramelteon].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20090801

Title: Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.

Journal: Psychopharmacology 20090701

Title: Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat.

Journal: Neuroscience letters 20090626

Title: Emerging therapies for sleep disorders.

Journal: British journal of hospital medicine (London, England : 2005) 20090601

Title: Ramelteon: a review of its therapeutic potential in sleep disorders.

Journal: Advances in therapy 20090601

Title: Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.

Journal: Prescrire international 20090601

Title: Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.

Journal: Current medical research and opinion 20090501

Title: Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study.

Journal: The Journal of clinical psychiatry 20090401

Title: [Objection to a conclusion in Medicinske Nyheder].

Journal: Ugeskrift for laeger 20090330

Title: The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease.

Journal: Sleep & breathing = Schlaf & Atmung 20090301

Title: Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia.

Journal: Human psychopharmacology 20090301

Title: Ramelteon for the treatment of insomnia in menopausal women.

Journal: Menopause international 20090301

Title: Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.

Journal: Sleep 20090301

Title: Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090215

Title: Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090215

Title: Let there be sleep--on time.

Journal: Lancet (London, England) 20090207

Title: The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

Title: The effects of ramelteon in a first-night model of transient insomnia.

Journal: Sleep medicine 20090101

Title: Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.

Journal: CNS neuroscience & therapeutics 20090101

Title: Melatonin and melatonergic drugs on sleep: possible mechanisms of action.

Journal: The International journal of neuroscience 20090101

Title: New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.

Journal: Neuropsychiatric disease and treatment 20090101

Title: Comparative tolerability of newer agents for insomnia.

Journal: Drug safety 20090101

Title: Drugs associated with more suicidal ideations are also associated with more suicide attempts.

Journal: PloS one 20090101

Title: Algorithms for the assessment and management of insomnia in primary care.

Journal: Patient preference and adherence 20090101

Title: Can improving sleep influence sleep-disordered breathing?

Journal: Drugs 20090101

Title: Neurophysiology of sleep and wakefulness: basic science and clinical implications.

Journal: Current neuropharmacology 20081201

Title: Circadian phase-shifting effects of repeated ramelteon administration in healthy adults.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20081015

Title: Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat.

Journal: Critical care medicine 20081001

Title: Melatonin and its agonists: an update.

Journal: The British journal of psychiatry : the journal of mental science 20081001

Title: The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity.

Journal: Sleep 20081001

Title: Ramelteon: new drug. Insomnia: no role for risky placebos.

Journal: Prescrire international 20081001

Title: Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.

Journal: Neuroscience 20080909

Title: Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.

Journal: Journal of pineal research 20080901

Title: Ramelteon: a novel approach in the treatment of insomnia.

Journal: The Annals of pharmacotherapy 20080901

Title: Sleep dysfunction in heart failure.

Journal: Current treatment options in neurology 20080901

Title: Hypnotics and skin cancer: hint at drug carcinogenesis, coincidence, or benefit of more sleep?

Journal: Journal of sleep research 20080901

Title: Possibility that certain hypnotics might cause cancer in skin.

Journal: Journal of sleep research 20080901

Title: Effect of ramelteon, a selective MT(1)/MT (2)-receptor agonist, on respiration during sleep in mild to moderate COPD.

Journal: Sleep & breathing = Schlaf & Atmung 20080801

Title: Efficacy and clinical safety of ramelteon: an evidence-based review.

Journal: Sleep medicine reviews 20080801

Title: Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells.

Journal: Neuroscience letters 20080704

Title: Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.

Journal: Clinical therapeutics 20080701

Title: Pharmacotherapy for insomnia.

Journal: Clinics in geriatric medicine 20080201

Title: A review of ramelteon in the treatment of sleep disorders.

Journal: Neuropsychiatric disease and treatment 20080201

Title: [Drugs for insomnia and improving quality of life (QOL): research and development of ramelteon, an MT1/MT2-receptor agonist].

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20080101

Title: Ramelteon: a melatonin receptor agonist for the treatment of insomnia.

Journal: Journal of postgraduate medicine 20080101

Title: Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.

Journal: Travel medicine and infectious disease 20080101

Title: Melatonergic drugs in clinical practice.

Journal: Arzneimittel-Forschung 20080101

Title: Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial.

Journal: Critical care (London, England) 20080101

Title: Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders.

Journal: Current topics in medicinal chemistry 20080101

Title: Ramelteon: a review of its use in insomnia.

Journal: Drugs 20080101

Title: Indiplon in the treatment of sleep disorders.

Journal: Neuropsychiatric disease and treatment 20071201

Title: In search of novel and therapeutically significant melatoninergic ligands.

Journal: Recent patents on CNS drug discovery 20071101

Title: Design and synthesis of new N1 and C3-substituted 4-fluoroindolic melatoninergics.

Journal: Current drug discovery technologies 20071001

Title: Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology 20071001

Title: Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea.

Journal: Sleep & breathing = Schlaf & Atmung 20070901

Title: Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.

Journal: The American journal of geriatric pharmacotherapy 20070901

Title: Eszopiclone for late-life insomnia.

Journal: Clinical interventions in aging 20070901

Title: Ramelteon: a novel hypnotic indicated for the treatment of insomnia.

Journal: Psychiatry (Edgmont (Pa. : Township)) 20070901

Title: Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20070815

Title: Treatment options for insomnia.

Journal: American family physician 20070815

Title: Putting 'sleepdriving' and new safety warning in perspective.

Journal: The Johns Hopkins medical letter health after 50 20070801

Title: Eszopiclone: its use in the treatment of insomnia.

Journal: Neuropsychiatric disease and treatment 20070801

Title: New perspectives for the treatment of disorders of sleep and arousal.

Journal: Annales pharmaceutiques francaises 20070701

Title: Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.

Journal: Current medical research and opinion 20070601

Title: The management of insomnia in the older adult.

Journal: Medicine and health, Rhode Island 20070601

Title: Hypnotic sedative drugs.

Journal: Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 20070601

Title: A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.

Journal: Current medical research and opinion 20070501

Title: Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2.

Journal: Journal of clinical pharmacology 20070401

Title: Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.

Journal: Nature clinical practice. Neurology 20070401

Title: Putting insomnia to rest.

Journal: The Nurse practitioner 20070401

Title: Therapeutic options for sleep-maintenance and sleep-onset insomnia.

Journal: Pharmacotherapy 20070101

Title: [Recent and potential drugs for treatment of insomnia].

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070101

Title: Use of non-benzodiazepine hypnotics in the elderly: are all agents the same?

Journal: CNS drugs 20070101

Title: [Melatonin, melatonin receptor agonists and tryptophan as sleep aids].

Journal: Pharmazie in unserer Zeit 20070101

Title: Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.

Journal: Primary care companion to the Journal of clinical psychiatry 20070101

Title: Greater incidence of depression with hypnotic use than with placebo.

Journal: BMC psychiatry 20070101

Title: Role of the melatonin system in the control of sleep: therapeutic implications.

Journal: CNS drugs 20070101

Title: [New hypnotics: perspectives from sleep physiology].

Journal: Vertex (Buenos Aires, Argentina) 20070101

Title: Treating insomnia: Current and investigational pharmacological approaches.

Journal: Pharmacology & therapeutics 20061201

Title: Pharmacologic management of insomnia: past, present, and future.

Journal: The Psychiatric clinics of North America 20061201

Title: Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.

Journal: Archives of general psychiatry 20061001

Title: Ramelteon for insomnia in two youths with autistic disorder.

Journal: Journal of child and adolescent psychopharmacology 20061001

Title: Ramelteon for the treatment of insomnia.

Journal: Clinical therapeutics 20061001

Title: A new sleeping pill.

Journal: The Harvard mental health letter 20061001

Title: Treatment of sleep dysfunction and psychiatric disorders.

Journal: Current treatment options in neurology 20060901

Title: Associated Professional Sleep Societies--SLEEP 2006 20th Anniversary Meeting. 17-22 June 2006, Salt Lake City, UT, USA.

Journal: IDrugs : the investigational drugs journal 20060901

Title: Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II.

Journal: Journal of psychiatric practice 20060901

Title: New drugs 06, part II.

Journal: Nursing 20060801

Title: Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice.

Journal: Neuroscience letters 20060724

Title: Ramelteon: a novel treatment for the treatment of insomnia.

Journal: Expert review of neurotherapeutics 20060701

Title: Searching for new options for treating insomnia: are melatonin and ramelteon beneficial?

Journal: Journal of psychiatric practice 20060701

Title: Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

Journal: Sleep medicine 20060601

Title: Acute and chronic effects of ramelteon in rhesus monkeys (Macaca mulatta): dependence liability studies.

Journal: Behavioral neuroscience 20060601

Title: Management of chronic insomnia in elderly persons.

Journal: The American journal of geriatric pharmacotherapy 20060601

Title: Depression and sleep: pathophysiology and treatment.

Journal: Dialogues in clinical neuroscience 20060601

Title: Consultation corner. Are the new sleep aids right for you?

Journal: The Johns Hopkins medical letter health after 50 20060401

Title: Potential therapeutic use of melatonin in migraine and other headache disorders.

Journal: Expert opinion on investigational drugs 20060401

Title: Ramelteon (rozerem) a novel approach for insomnia treatment.

Journal: The Nurse practitioner 20060401

Title: Practical considerations of new drugs: new choices for old problems.

Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060401

Title: Ramelteon: profile of a new sleep-promoting medication.

Journal: Drugs of today (Barcelona, Spain : 1998) 20060401

Title: Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia.

Journal: Journal of clinical pharmacology 20060201

Title: A look back at the most influential drug approvals of 2005.

Journal: The Nurse practitioner 20060201

Title: Recommendations for assessing insomnia.

Journal: The Nurse practitioner 20060201

Title: An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.

Journal: Sleep medicine 20060101

Title: New drugs: ramelteon, tipranavir, nepafenac, and deferasirox.

Journal: Journal of the American Pharmacists Association : JAPhA 20060101

Title: Use of sleep-promoting medications in nursing home residents : risks versus benefits.

Journal: Drugs & aging 20060101

Title: Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology 20060101

Title: Melatonin and sleep in aging population.

Journal: Experimental gerontology 20051201

Title: Ramelteon (Rozerem) for insomnia.

Journal: The Medical letter on drugs and therapeutics 20051107

Title: Fresh from the pipeline: Ramelteon.

Journal: Nature reviews. Drug discovery 20051101

Title: Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology 20051001

Title: New drugs and dosage forms.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050915

Title: Recent advances in melatonin receptor ligands.

Journal: Archiv der Pharmazie 20050601

Title: Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology 20050401

Title: Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.

Journal: Sleep 20050301

Title: Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats.

Journal: Journal of biological rhythms 20050201

Title: Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.

Journal: Neuropharmacology 20050201

Title: TAK-375 Takeda.

Journal: Current opinion in investigational drugs (London, England : 2000) 20050101

Title: Ramelteon: TAK 375.

Journal: Drugs in R&D 20050101

Title: Ramelteon.

Journal: CNS drugs 20050101

Title: Sleep and aging: prevalence of disturbed sleep and treatment considerations in older adults.

Journal: The Journal of clinical psychiatry 20050101

Title: Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds.

Journal: The Journal of clinical psychiatry 20050101

Title: Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology 20041201

Title: Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys.

Journal: Brain research 20041119

Title: Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists.

Journal: Sleep medicine 20041101

Title: The sleep-promoting action of ramelteon (TAK-375) in freely moving cats.

Journal: Sleep 20041101

Title: Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology 20041101

Title: Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology 20040101

Title: Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology 20031101

Title: Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.

Journal: Journal of medicinal chemistry 20020912

Title: Kato K, et al. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology. 2005;48(2):301-310.

Title: Mayer G, et al. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep. 2009;32(3):351-360.

Title: Hirai K, et al. Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats. J Biol Rhythms. 2005;20(1):27-37.

Title: Miyamoto M, et al. The sleep-promoting action of ramelteon (TAK-375) in freely moving cats. Sleep. 2004;27(7):1319-1325.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:196597-26-9 Molecular Formula|196597-26-9 MDL|196597-26-9 SMILES|196597-26-9 (S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide